Eledon Pharmaceuticals Banner Image

Eledon Pharmaceuticals

  • Ticker ELDN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eledon Pharmaceuticals Logo Image
  • 1-10 Employees
  • Based in Irvine, California
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. Their lead program, AT-1501, is a potential best-in-class humanized IgG1 anti-CD40L antibody with high affinity forMore CD40L, a well-validated biological target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.
4.8 / 5.0 (182)

Eledon Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 182 reviews.

Eledon Pharmaceuticals

Most Recent Annual Report

Eledon Pharmaceuticals
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Eledon Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!